Literature DB >> 12534310

Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Claudio N Soares1, Jennifer R Poitras, Jennifer Prouty.   

Abstract

Periods of intense hormonal fluctuations have been associated with heightened prevalence and exacerbation of underlying psychiatric illness, particularly the occurrence of premenstrual dysphoria, puerperal depression and depressive symptoms during perimenopause. It has been speculated that sex steroids such as estrogens, progestogens, testosterone and dehydroepiandrosterone (DHEA) exert a significant modulation of brain functioning, possibly through interactions with various neurotransmitter systems. It is therefore intuitive that abrupt alterations of these hormones would interfere with mood and behaviour. On the other hand, accumulating data suggest that hormonal interventions may also promote relief or even remission of depressive symptoms, as already demonstrated in studies with patients experiencing postpartum depression and perimenopausal depressive disorders. The extent to which perimenopause, alone, may increase the risk for depression is unclear. However, existing data strongly suggest that some women are particularly vulnerable to developing significant physical and psychological disturbances when entering perimenopause. This article reviews the effect of sex hormones and selective estrogen receptor modulators (SERMs) on mood among peri- and postmenopausal women. There are preliminary, though promising, data on the use of estradiol (particularly transdermal estradiol) to alleviate depression during perimenopause, use of a combination of estrogens and selective serotonin reuptake inhibitors for depression during the postmenopausal period, and the use of testosterone to improve psychological well-being and increase libido among women with induced menopause. Further studies would help to better delineate the usage of hormones as an antidepressant strategy (monotherapy or augmenting treatment) for peri- and postmenopausal women. A brief review of some nonhormonal interventions for the treatment of menopause-related symptoms that may significantly affect a woman's quality of life is also presented. There are some preliminary data suggesting the efficacy of antidepressants for the treatment of hot flushes; existing data on diet supplements and herbal products have shown more mixed results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534310     DOI: 10.2165/00002512-200320020-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  107 in total

1.  Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study.

Authors:  K Yaffe; B Ettinger; A Pressman; D Seeley; M Whooley; C Schaefer; S Cummings
Journal:  Biol Psychiatry       Date:  1998-05-01       Impact factor: 13.382

2.  Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study.

Authors:  A Ahokas; J Kaukoranta; K Wahlbeck; M Aito
Journal:  J Clin Psychiatry       Date:  2001-05       Impact factor: 4.384

3.  Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women.

Authors:  G C George; W H Utian; P J Beaumont; C J Beardwood
Journal:  S Afr Med J       Date:  1973-12-15

4.  Hormones, sex, and status in women.

Authors:  E Cashdan
Journal:  Horm Behav       Date:  1995-09       Impact factor: 3.587

5.  The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period.

Authors:  S Haas; B Walsh; S Evans; M Krache; V Ravnikar; I Schiff
Journal:  Obstet Gynecol       Date:  1988-05       Impact factor: 7.661

Review 6.  Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans.

Authors:  O T Wolf; C Kirschbaum
Journal:  Brain Res Brain Res Rev       Date:  1999-11

7.  Treatment of hot flushes with mirtazapine: four case reports.

Authors:  M D Waldinger; H H Berendsen; D H Schweitzer
Journal:  Maturitas       Date:  2000-10-31       Impact factor: 4.342

8.  Mood effect of raloxifene in postmenopausal women.

Authors:  Natalia B Jarkova; Ferenc Martenyi; Daiva Masanauskaite; Erin L Walls; Vera P Smetnik; Imre Pavo
Journal:  Maturitas       Date:  2002-05-20       Impact factor: 4.342

9.  Fluoxetine efficacy in menopausal women with and without estrogen replacement.

Authors:  J Amsterdam; F Garcia-España; J Fawcett; F Quitkin; F Reimherr; J Rosenbaum; C Beasley
Journal:  J Affect Disord       Date:  1999-09       Impact factor: 4.839

Review 10.  Role of female gonadal hormones in the CNS: clinical and experimental aspects.

Authors:  A Maggi; J Perez
Journal:  Life Sci       Date:  1985-09-09       Impact factor: 5.037

View more
  16 in total

1.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 2.  [The effects of hormone replacement therapy on mind and brain].

Authors:  P Baldinger; G Kranz; A Höflich; M Savli; P Stein; R Lanzenberger; S Kasper
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

Review 3.  Effects of Sex Steroids in the Human Brain.

Authors:  Tuong-Vi Nguyen; Simon Ducharme; Sherif Karama
Journal:  Mol Neurobiol       Date:  2016-11-08       Impact factor: 5.590

4.  Ovarian steroids increase spinogenetic proteins in the macaque dorsal raphe.

Authors:  H M Rivera; C L Bethea
Journal:  Neuroscience       Date:  2012-02-08       Impact factor: 3.590

5.  Ovarian steroids increase PSD-95 expression and dendritic spines in the dorsal raphe of ovariectomized macaques.

Authors:  Heidi M Rivera; Cynthia L Bethea
Journal:  Synapse       Date:  2013-09-12       Impact factor: 2.562

6.  Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016.

Authors:  Anitha Jeyagurunathan; Edimansyah Abdin; Janhavi Ajit Vaingankar; Boon Yiang Chua; Saleha Shafie; Shi Hui Sherilyn Chang; Lyn James; Kelvin Bryan Tan; Sutapa Basu; Siow Ann Chong; Mythily Subramaniam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-08-27       Impact factor: 4.328

7.  Effect of ovarian steroids on gene expression related to synapse assembly in serotonin neurons of macaques.

Authors:  Cynthia L Bethea; Arubala P Reddy
Journal:  J Neurosci Res       Date:  2012-03-13       Impact factor: 4.164

Review 8.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

9.  Antidepressants, sex steroids and pituitary-adrenal response in sheep.

Authors:  Jillian H Broadbear; Thao Nguyen; Iain J Clarke; Benedict J Canny
Journal:  Psychopharmacology (Berl)       Date:  2004-03-03       Impact factor: 4.530

10.  The unique challenges of managing depression in mid-life women.

Authors:  Lorraine Dennerstein; Claudio N Soares
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.